Stable isotope dilution mass spectrometry for membrane transporter quantitation

AAPS Journal

Volumn 15, Issue 4, 2013, Pages 1222-1231

  Farrokhi, Vahid ^a   McShane, Adam J ^a   Nemati, Reza ^a   Yao, Xudong ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

mass spectrometry; membrane protein; membrane proteome; membrane transporter; quantitative proteomics; stable isotope dilution; stable isotope labeling

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AQUAPORIN; BREAST CANCER RESISTANCE PROTEIN; CALMYRIN; CARBONATE DEHYDRATASE IX; CONNEXIN 46; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 8; GLUCOSE TRANSPORTER 1; GLYPICAN; ISOTOPE; LIPOCORTIN 4; MEMBRANE PROTEIN; MICROSOMAL AMINOPEPTIDASE; MITOCHONDRIAL PROTEIN; MOESIN; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; NEUROLIGIN; NEUROLIGIN 4; POTASSIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; RHODOPSIN; SQUALENE SYNTHASE; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VIMENTIN; VOLTAGE DEPENDENT ANION CHANNEL; VOLTAGE DEPENDENT ANION CHANNEL 1; VOLTAGE DEPENDENT ANION CHANNEL 2; VOLTAGE DEPENDENT ANION CHANNEL PROTEIN 1;

ARTICLE; HUMAN; ISOTOPE DILUTION ASSAY; ISOTOPE LABELING; MASS SPECTROMETRY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PROCESSING;

ANIMALS; CELL MEMBRANE; HUMANS; ISOTOPE LABELING; MASS SPECTROMETRY; MEMBRANE TRANSPORT PROTEINS;

EID: 84887999344     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-013-9529-8     Document Type: Article

References (90)

1. Wu CC, MacCoss MJ, Howell KE, Yates III JR. A method for the comprehensive proteomic analysis of membrane proteins. Nat Biotechnol. 2003;21:532-8.
2. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002;1:727-30.
3. Walther TC, Mann M. Mass spectrometry-based proteomics in cell biology. J Cell Biol. 2010;190:491-500.
4. Boja ES, Rodriguez H. Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins. Proteomics. 2012;12:1093-110.
5. Liebler DC, Zimmerman LJ. Targeted quantitation of proteins by mass spectrometry. Biochemistry. 2013;22:3797-806.
6. Deo AK, Prasad B, Balogh L, Lai Y, Unadkat JD. Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): quantification by liquid chromatography/tandem mass spectrometry. Drug Metab Dispos. 2012;40:852-5.
7. Fortin T, Salvador A, Charrier JP, Lenz C, Bettsworth F, Lacoux X, et al. Multiple reaction monitoring cubed for protein quantification at the low nanogram/milliliter level in nondepleted human serum. Anal Chem. 2009;81:9343-52.
8. Prasad B, Lai Y, Lin Y, Unadkat JD. Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype. J Pharm Sci. 2013;102:787-93.
9. Rees DC, Johnson E, Lewinson O. ABC transporters: the power to change. Nat Rev Mol Cell Biol. 2009;10:218-27.
10. Huang Y, Anderle P, Bussey KJ, Barbacioru C, Shankavaram U, Dai Z, et al. Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res. 2004;64:4294-301.
11. Saier Jr MH, Tran CV, Barabote RD. TCDB: the Transporter Classification Database for membrane transport protein analyses and information. Nucleic Acids Res. 2006;34:D181-6.
12. Busch W, Saier Jr MH. The IUBMB-endorsed transporter classification system. Mol Biotechnol. 2004;27:253-62.
13. Russel FGM. Transporters: importance in drug absorption, distribution, and removal. Enzyme- Transp-Based Drug-Drug Interact. 2010:27-49.
14. Lee HJ, Sagawa K, Shi W, Murer H, Morris ME. Hormonal regulation of sodium/sulfate co-transport in renal epithelial cells. Proc Soc Exp Biol Med. 2000;225:49-57.
15. Saier Jr MH. A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol Mol Biol Rev. 2000;64:354-411.
16. Schmitt S, Kury S, Giraud M, Dreno B, Kharfi M, Bezieau S. An update on mutations of the SLC39A4 gene in acrodermatitis enteropathica. Hum Mutat. 2009;30:926-33.
17. Akiyama M. ABCA12 mutations and autosomal recessive congenital ichthyosis: a review of genotype/phenotype correlations and of pathogenetic concepts. Hum Mutat. 2010;31:1090-6.
18. Clancy JP, Jain M. Personalized medicine in cystic fibrosis: dawning of a new era. Am J Respir Crit Care Med. 2012;186:593-7.
19. Chillaron J, Font-Llitjos M, Fort J, Zorzano A, Goldfarb DS, Nunes V, et al. Pathophysiology and treatment of cystinuria. Nat Rev Nephrol. 2010;6:424-34.
20. Broer S, Wagner CA. Membrane transporter diseases. New York: Kluwer/Plenum; 2003.
21. Savas JN, Stein BD, Wu CC, Yates III JR. Mass spectrometry accelerates membrane protein analysis. Trends Biochem Sci. 2011;36:388-96.
22. Adams R, Worth CL, Guenther S, Dunkel M, Lehmann R, Preissner R. Binding sites in membrane proteins-diversity, druggability and prospects. Eur J Cell Biol. 2012;91:326-39.
23. Emi Y, Yasuda Y, Sakaguchi M. A cis-acting five-amino-acid motif controls targeting of ABCC2 to the apical plasma membrane domain. J Cell Sci. 2012;125:3133-43.
24. Higgins CF. Multiple molecular mechanisms for multidrug resistance transporters. Nature. 2007;446:749-57.
25. Tien WS, Chen YT, Wu KP. SecretePipe: a screening pipeline for secreted proteins with competence to identify potential membrane-bound shed markers. J Proteome Res. 2013;12:1235-44.
26. Yang Y, Toy W, Choong LY, Hou P, Ashktorab H, Smoot DT, et al. Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications in molecular imaging. J Proteome Res. 2012;11:5736-47.
27. Zhang P, Zeng G, Hu R, Li C, Yi H, Li M, et al. Identification of Flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis. J Proteome. 2012;77:202-14.
28. Vuckovic D, Dagley LF, Purcell AW, Emili A. Membrane proteomics by high performance liquid chromatography-tandem mass spectrometry: analytical approaches and challenges. Proteomics. 2013;13:404-23.
29. Faca VM, Ventura AP, Fitzgibbon MP, Pereira-Faca SR, Pitteri SJ, Green AE, et al. Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains. PLoS One. 2008;3:e2425.
30. Karhemo PR, Ravela S, Laakso M, Ritamo I, Tatti O, Makinen S, et al. An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis. J Proteome. 2012;77:87-100.
31. Ramjeesingh M, Li C, Garami E, Huan LJ, Hewryk M, Wang Y, et al. A novel procedure for the efficient purification of the cystic fibrosis transmembrane conductance regulator (CFTR). Biochem J. 1997;327(Pt 1):17-21.
32. Choksawangkarn W, Kim S, Cannon JR, Edwards NJ, Lee SB, Fenselau C. Enrichment of plasma membrane proteins using nanoparticle pellicles: comparison between silica and higher density nanoparticles. J Proteome Res. 2013;12:1134-41.
33. Rahbar AM, Fenselau C. Integration of Jacobson's pellicle method into proteomic strategies for plasma membrane proteins. J Proteome Res. 2004;3:1267-77.
34. Li B, Chang J, Chu Y, Kang H, Yang J, Jiang J, et al. Membrane proteomic analysis comparing squamous cell lung cancer tissue and tumour-adjacent normal tissue. Cancer Lett. 2012;319:118-24.
35. Nair S, Xavier T, Kumar MK, Saha S, Menon KN. Exploitation of detergent thermodynamics in the direct solubilization of myelin membrane proteins for two-dimensional gel electrophoresis for proteomic analysis. Electrophoresis. 2011;32:3621-9.
36. Perdomo AB, Ciccosanti F, Iacono OL, Angeletti C, Corazzari M, Daniele N, et al. Liver protein profiling in chronic hepatitis C: identification of potential predictive markers for interferon therapy outcome. J Proteome Res. 2012;11:717-27.
37. Mitra SK, Walters BT, Clouse SD, Goshe MB. An efficient organic solvent based extraction method for the proteomic analysis of Arabidopsis plasma membranes. J Proteome Res. 2009;8:2752-67.
38. Yun S, Choi C, Kwon S, Park GW, Cho K, Kwon K, et al. Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii. J Proteome Res. 2011;10:459-69.
39. Hogl S, van Bebber F, Dislich B, Kuhn P, Haass C, Schmid B, et al. Label-free quantitative analysis of the membrane proteome of Bace1 protease knock-out zebrafish brains. Proteomics. 2013;13:1519-27.
40. Choksawangkarn W, Edwards N, Wang Y, Gutierrez P, Fenselau C. Comparative study of workflows optimized for in-gel, in-solution, and on-filter proteolysis in the analysis of plasma membrane proteins. J Proteome Res. 2012;11:3030-4.
41. Fischer F, Wolters D, Roegner M, Poetsch A. Toward the complete membrane proteome: high coverage of integral membrane proteins through transmembrane peptide detection. Mol Cell Proteomics. 2006;5:444-53.
42. Yates JR, Ruse CI, Nakorchevsky A. Proteomics by mass spectrometry: approaches, advances, and applications. Annu Rev Biomed Eng. 2009;11:49-79.
43. Manadas B, English JA, Wynne KJ, Cotter DR, Dunn MJ. Comparative analysis of OFFGel, strong cation exchange with pH gradient, and RP at high pH for first-dimensional separation of peptides from a membrane-enriched protein fraction. Proteomics. 2009;9:5194-8.
44. Niessen J, Jedlitschky G, Grube M, Kawakami H, Kamiie J, Ohtsuki S, et al. Expression of ABC-type transport proteins in human platelets. Pharmacogenet Genomics. 2010;20:396-400.
45. Uchida Y, Ohtsuki S, Katsukura Y, Ikeda C, Suzuki T, Kamiie J, et al. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem. 2011;117:333-45.
46. Sadowski PG, Dunkley TP, Shadforth IP, Dupree P, Bessant C, Griffin JL, et al. Quantitative proteomic approach to study subcellular localization of membrane proteins. Nat Protoc. 2006;1:1778-89.
47. Gillette MA, Carr SA. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat Methods. 2013;10:28-34.
48. Bantscheff M, Lemeer S, Savitski MM, Kuster B. Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present. Anal Bioanal Chem. 2012;404:939-65.
49. Martinez-Aguilar J, Chik J, Nicholson J, Semaan C, McKay MJ, Molloy MP. Quantitative mass spectrometry for colorectal cancer proteomics. Proteomics Clin Appl. 2013;7:42-54.
50. Yocum AK, Chinnaiyan AM. Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry. Brief Funct Genomic Proteomics. 2009;8:145-57.
51. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A. 2003;100:6940-5.
52. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 1999;17:994-9.
53. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics. 2004;3:1154-69.
54. Thompson A, Schafer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem. 2003;75:1895-904.
55. Barnidge DR, Dratz EA, Martin T, Bonilla LE, Moran LB, Lindall A. Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal Chem. 2003;75:445-51.
56. Han DK, Eng J, Zhou H, Aebersold R. Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat Biotechnol. 2001;19:946-51.
57. Stella R, Cifani P, Peggion C, Hansson K, Lazzari C, Bendz M, et al. Relative quantification of membrane proteins in wild-type and prion protein (PrP)-knockout cerebellar granule neurons. J Proteome Res. 2012;11:523-36.
58. Kamiie J, Ohtsuki S, Iwase R, Ohmine K, Katsukura Y, Yanai K, et al. Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm Res. 2008;25:1469-83.
59. Miliotis T, Ali L, Palm JE, Lundqvist AJ, Ahnoff M, Andersson TB, et al. Development of a highly sensitive method using liquid chromatography-multiple reaction monitoring to quantify membrane P-glycoprotein in biological matrices and relationship to transport function. Drug Metab Dispos. 2011;39:2440-9.
60. Niessen J, Jedlitschky G, Grube M, Bien S, Schwertz H, Ohtsuki S, et al. Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin. Drug Metab Dispos. 2009;37:1129-37.
61. Whiteaker JR, Zhao L, Anderson L, Paulovich AG. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol Cell Proteomics. 2010;9:184-96.
62. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol. 2006;24:971-83.
63. Schiess R, Wollscheid B, Aebersold R. Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol. 2009;3:33-44.
64. Yao X, Bajrami B, Shi Y. Ultrathroughput multiple reaction monitoring mass spectrometry. Anal Chem. 2010;82:794-7.
65. Nanavati D, Gucek M, Milne JL, Subramaniam S, Markey SP. Stoichiometry and absolute quantification of proteins with mass spectrometry using fluorescent and isotope-labeled concatenated peptide standards. Mol Cell Proteomics. 2008;7:442-7.
66. Ito K, Uchida Y, Ohtsuki S, Aizawa S, Kawakami H, Katsukura Y, et al. Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys. J Pharm Sci. 2011;100:3939-50.
67. Ohtsuki S, Ikeda C, Uchida Y, Sakamoto Y, Miller F, Glacial F, et al. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model. Mol Pharm. 2013;10:289-96.
68. Jiang H, Ramos AA, Yao X. Targeted quantitation of overexpressed and endogenous cystic fibrosis transmembrane conductance regulator using multiple reaction monitoring tandem mass spectrometry and oxygen stable isotope dilution. Anal Chem. 2010;82:336-42.
69. 18O-labeling to identify biomarkers for cholangiocarcinoma. J Proteome Res. 2008;7:4670-7.
70. Stockwin LH, Blonder J, Bumke MA, Lucas DA, Chan KC, Conrads TP, et al. Proteomic analysis of plasma membrane from hypoxia-adapted malignant melanoma. J Proteome Res. 2006;5:2996-3007.
71. 18O labeling. J Proteome Res. 2010;9:2160-9.
72. Blonder J, Yu LR, Radeva G, Chan KC, Lucas DA, Waybright TJ, et al. Combined chemical and enzymatic stable isotope labeling for quantitative profiling of detergent-insoluble membrane proteins isolated using Triton X-100 and Brij-96. J Proteome Res. 2006;5:349-60.
73. Chen X, Walker AK, Strahler JR, Simon ES, Tomanicek-Volk SL, Nelson BB, et al. Organellar proteomics: analysis of pancreatic zymogen granule membranes. Mol Cell Proteomics. 2006;5:306-12.
74. Yun SH, Choi CW, Kwon SO, Park GW, Cho K, Kwon KH, et al. Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii. J Proteome Res. 2011;10:459-69.
75. Truscott RJ, Comte-Walters S, Ablonczy Z, Schwacke JH, Berry Y, Korlimbinis A, et al. Tight binding of proteins to membranes from older human cells. Age (Dordr). 2011;33:543-54.
76. Everley PA, Krijgsveld J, Zetter BR, Gygi SP. Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol Cell Proteomics. 2004;3:729-35.
77. Prokhorova TA et al. Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells. Mol Cell Proteomics. 2009;8.5:959-70.
78. Rahbar AM, Fenselau C. Unbiased examination of changes in plasma membrane proteins in drug resistant cancer cells. J Proteome Res. 2005;4:2148-53.
79. Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J Proteome Res. 2004;3:235-44.
80. 2H-labeled peptides for targeted quantitative proteomics. Int J Mass Spectrom. 2012;312:17-23.
81. Li N, Palandra J, Nemirovskiy OV, Lai Y. LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species. Anal Chem. 2009;81:2251-9.
82. 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal Chem. 2001;73:2836-42.
83. Niles R, Witkowska HE, Allen S, Hall SC, Fisher SJ, Hardt M. Acid-catalyzed oxygen-18 labeling of peptides. Anal Chem. 2009;81:2804-9.
84. 18 labeling: hydrolysis-driven deamidation. Anal Chem. 2011;83:7227-32.
85. Oda Y, Huang K, Cross FR, Cowburn D, Chait BT. Accurate quantitation of protein expression and site-specific phosphorylation. Proc Natl Acad Sci U S A. 1999;96:6591-6.
86. An E, Sen S, Park SK, Gordish-Dressman H, Hathout Y. Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome. Investig Ophthalmol Vis Sci. 2010;51:3379-86.
87. Brun V, Dupuis A, Adrait A, Marcellin M, Thomas D, Court M, et al. Isotope-labeled protein standards: toward absolute quantitative proteomics. Mol Cell Proteomics. 2007;6:2139-49.
88. Geiger T, Cox J, Ostasiewicz P, Wisniewski JR, Mann M. Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat Methods. 2010;7:383-5.
89. McClatchy DB, Yates III JR. Stable Isotope Labeling of Mammals (SILAM). CSH Protocol. 2008. doi: 10.1101/pdb.prot4940.
90. Brown KJ, Marathi R, Fiorillo AA, Ciccimaro EF, Sharma S, Rowlands DS, et al. Accurate quantitation of dystrophin protein in human skeletal muscle using mass spectrometry. J Bioanalysis Biomed. 2012. doi: 10.4172/1948-593X.S7-001.